tirzepatide updates today Mission Family Medicine launches in-clinic program Tirzepatide trial shows additional 21.1%

But that changed in 2025

Pain Relief : Patients diagnosed with arthritis, joint inflammation, and other chronic pain conditions have reported improvements in their discomfort after receiving low doses of tirzepatide

Monitor blood glucose more frequently if you suspect your tirzepatide has been compromised by heat exposure

Report any neck mass, swallowing difficulty, or hoarseness

(Mounjaro and Zepbound) Tirzepatide is a newer class of medication a dual GIP and GLP-1 receptor agonist

Avoid hot showers (use lukewarm water), limit exfoliation to once per week, and wear sunscreen dailyUV exposure worsens dryness and accelerates skin barrier damage